Speaker Details

David Miller, MD, PhD, FAAD

David Miller, MD, PhD, FAAD

SESSIONS

F065 What's New in the Management of Advanced Skin Cancer
Mar 9, 2024 • 3:30 PM - 5:30 PM • Room 31B
S045 Updates in Cutaneous Oncology
Mar 10, 2024 • 1:00 PM - 4:00 PM • Room 24C

DISCLOSURES

Castle Biosciences – Advisory Board(Stock); Checkpoint Therapeutics – Advisory Board(Honoraria); EMD Serono – Advisory Board(Honoraria); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);